Zobrazeno 1 - 10
of 72
pro vyhledávání: '"E. A. Kraut"'
Autor:
E. H. Kraut, Everett E. Vokes, Ann M. Mauer, Stuart A. Krauss, Kristen Kasza, Livia Szeto, Rafat Ansari
Publikováno v:
Annals of Oncology. 16:1320-1325
Background: The aim of the study was to evaluate the efficacy and tolerability of the combination of oxaliplatin, fluorouracil and leucovorin in patients with advanced esophagus cancer. Patients and methods: Thirty-five patients with recurrent or met
Publikováno v:
Journal of Burn Care & Rehabilitation. 14:552-556
Ischemic necrosis of the upper extremities caused by invasive mucormycosis developed in a patient with soil contamination of severe burn wounds. An arteriogram of the arm showed complete obstruction of blood flow in the forearm. Histologic specimens
Publikováno v:
Journal of Applied Physics. 69:372-378
X‐ray photoemission spectroscopy (XPS) has been used to measure the valence‐band offset ΔEv for the lattice‐matched InP/ In0.53Ga0.47As and In0.53Ga0.47As/ In0.52Al0.48As heterojunction interfaces. The heterojunctions were formed by molecular�
Autor:
F R, Appelbaum, M R, Baer, M H, Carabasi, S E, Coutre, H P, Erba, E, Estey, M J, Glenn, E H, Kraut, P, Maslak, M, Millenson, C B, Miller, H I, Saba, R, Stone, M S, Tallman
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
Autor:
E H, Kraut
Publikováno v:
Seminars in oncology. 27(2 Suppl 5)
Hairy cell leukemia (HCL) is a chronic lymphoproliferative disease of B-cell origin manifested by pancytopenia and splenomegaly. Before 1980 the only effective treatment for HCL was splenectomy, which resolved the cytopenia but did not eliminate the
Autor:
C, Karanes, K J, Kopecky, D R, Head, M R, Grever, H E, Hynes, E H, Kraut, R H, Vial, A, Lichtin, S, Nand, W E, Samlowski, F R, Appelbaum
Publikováno v:
Leukemia research. 23(9)
The aim of this study is to determine whether the addition of mitoxantrone to high dose cytarabine improves the outcome of treatment in patients with relapsed or refractory acute myeloid leukemia (AML). One hundred and sixty-two eligible patients, 14
Publikováno v:
Seminars in hematology. 35(3 Suppl 4)
The standard treatment of multiple myeloma is systemic chemotherapy. Despite 30 years of drug development in myeloma, there are no new drug regimens significantly superior to melphalan and prednisone. In addition, phase II studies of new drugs in mye
Publikováno v:
Blood. 84(12)
Twenty-four patients with advanced hairy cell leukemia treated with 2'-deoxycoformycin (dCF) were studied after achieving complete remission to determine the impact of treatment on survival, disease-free survival, long-term complications of treatment
Publikováno v:
Cancer research. 53(20)
The sodium salt of pyrazine-2-diazohydroxide (PZDH; NSC 361456) was identified as an active congener of the antitumor lead pyridine-2-diazotate with enhanced chemical stability under physiological conditions. In a phase I trial of PZDH administered a
Publikováno v:
Leukemia. 6(8)
Hairy cell leukemia is a malignant B-cell disorder characterized by splenomegaly and pancytopenia. The malignant cell is morphologically unique and characterized by fine cytoplasmic projections. Although studies of the cell have revealed important in